A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX)
View abstract on PubMed
Summary
This summary is machine-generated.This trial investigates if less frequent CT scans improve survival for non-small cell lung cancer patients post-surgery. It compares standard surveillance against a less intensive approach to determine the optimal follow-up strategy.
Area Of Science
- Oncology
- Thoracic Surgery
- Radiology
Background
- Postoperative surveillance for non-small cell lung cancer (NSCLC) aims to detect recurrence and second primary tumors for timely curative treatment.
- Current guidelines recommend frequent computed tomography (CT) scans, but evidence supporting their survival benefit, particularly for locally advanced NSCLC, is limited.
Purpose Of The Study
- To confirm the non-inferiority of a less intensive surveillance strategy with reduced CT scan frequency compared to standard surveillance in terms of overall survival for NSCLC patients.
- To evaluate the effectiveness of optimized postoperative surveillance protocols in improving patient outcomes.
Main Methods
- A multi-institutional, randomized controlled phase III trial involving patients with pathological stage II and IIIA NSCLC.
- Comparison of less intensive surveillance (less frequent CT scans) versus standard surveillance (current guideline-recommended frequency).
- Primary endpoint is overall survival, with planned enrollment of 1100 patients across 45 institutions over 4 years.
Main Results
- Data collection and analysis are ongoing as the trial was launched in October 2022.
- The study is designed to provide robust evidence on the survival impact of different surveillance intensities.
Conclusions
- The trial aims to establish evidence-based recommendations for postoperative NSCLC surveillance, potentially leading to less burdensome and more cost-effective follow-up protocols.
- Findings will inform clinical practice guidelines regarding the optimal frequency of CT scans for NSCLC survivors.

